FDA Approves Femlyv (norethindrone acetate and ethinyl estradiol) Orally Disintegrating Birth Control Pill

July 23, 2024

FDA approves Femlyv, the first orally disintegrating birth control pill, on July 22, 2024, providing an alternative for individuals with difficulty swallowing medication.

Highlighted Terms

norethindrone acetate U.S. Food and Drug Administration ethinyl estradiol Femlyv FDA

Related News

drugs.com

FDA Approves Femlyv (norethindrone acetate and ethinyl estradiol) Orally Disintegrating Birth Control Pill

FDA approves Femlyv, the first orally disintegrating birth control pill, on July 22, 2024, providing an alternative for individuals with difficulty swallowing medication.